aluates Reports

$ 0.0

Automative

Global Immune-Mediated Inflammatory Diseases Treatment Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-1V2563

Global Immune Mediated Inflammatory Diseases Treatment Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Immune-Mediated Inflammatory Diseases Treatment Market Research Report 2025

Code: QYRE-Auto-1V2563

Report

September 2025

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astrazeneca plc

Bristol myers

Sanofi

Roche

Enlivex Therapeutics

Immune Pharmaceuticals

Tanabe Pharma

GlaxoSmithKline

GlaxoSmithKline PLC

Eli Lilly

Immune-Mediated Inflammatory Diseases Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Immune-Mediated Inflammatory Diseases Treatment Market

The global market for Immune-Mediated Inflammatory Diseases Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Immune-Mediated Inflammatory Diseases Treatment is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune response.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Immune-Mediated Inflammatory Diseases Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune-Mediated Inflammatory Diseases Treatment.

The Immune-Mediated Inflammatory Diseases Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immune-Mediated Inflammatory Diseases Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Immune-Mediated Inflammatory Diseases Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Immune-Mediated Inflammatory Diseases Treatment Market Report

Report Metric	Details
Report Name	Immune-Mediated Inflammatory Diseases Treatment Market
CAGR	5%
Segment by Type	Targeted biologic therapies Novel therapies
Segment by Application	Hospitals Pharmacy Store Online Pharmacy Stroe
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline, Eli Lilly, AstraZeneca, Bristol-Myers, Sanofi, Roche, Enlivex Therapeutics, Immune Pharmaceuticals, Tanabe Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immune-Mediated Inflammatory Diseases Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Immune-Mediated Inflammatory Diseases Treatment Market report?

Ans: The main players in the Immune-Mediated Inflammatory Diseases Treatment Market are GlaxoSmithKline, Eli Lilly, AstraZeneca, Bristol-Myers, Sanofi, Roche, Enlivex Therapeutics, Immune Pharmaceuticals, Tanabe Pharma

What are the Application segmentation covered in the Immune-Mediated Inflammatory Diseases Treatment Market report?

Ans: The Applications covered in the Immune-Mediated Inflammatory Diseases Treatment Market report are Hospitals, Pharmacy Store, Online Pharmacy Stroe

What are the Type segmentation covered in the Immune-Mediated Inflammatory Diseases Treatment Market report?

Ans: The Types covered in the Immune-Mediated Inflammatory Diseases Treatment Market report are Targeted biologic therapies, Novel therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Targeted biologic therapies

1.2.3 Novel therapies

1.3 Market by Application

1.3.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Pharmacy Store

1.3.4 Online Pharmacy Stroe

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Perspective (2020-2031)

2.2 Global Immune-Mediated Inflammatory Diseases Treatment Growth Trends by Region

2.2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Region (2020-2025)

2.2.3 Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Region (2026-2031)

2.3 Immune-Mediated Inflammatory Diseases Treatment Market Dynamics

2.3.1 Immune-Mediated Inflammatory Diseases Treatment Industry Trends

2.3.2 Immune-Mediated Inflammatory Diseases Treatment Market Drivers

2.3.3 Immune-Mediated Inflammatory Diseases Treatment Market Challenges

2.3.4 Immune-Mediated Inflammatory Diseases Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Revenue

3.1.1 Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Revenue (2020-2025)

3.1.2 Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Immune-Mediated Inflammatory Diseases Treatment Revenue

3.4 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio

3.4.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2024

3.5 Global Key Players of Immune-Mediated Inflammatory Diseases Treatment Head office and Area Served

3.6 Global Key Players of Immune-Mediated Inflammatory Diseases Treatment, Product and Application

3.7 Global Key Players of Immune-Mediated Inflammatory Diseases Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Immune-Mediated Inflammatory Diseases Treatment Breakdown Data by Type

4.1 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Type (2020-2025)

4.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Type (2026-2031)

5 Immune-Mediated Inflammatory Diseases Treatment Breakdown Data by Application

5.1 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Application (2020-2025)

5.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size (2020-2031)

6.2 North America Immune-Mediated Inflammatory Diseases Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025)

6.4 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size (2020-2031)

7.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025)

7.4 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size (2020-2031)

8.2 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size (2020-2031)

9.2 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025)

9.4 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size (2020-2031)

10.2 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Details

11.1.2 GlaxoSmithKline Business Overview

11.1.3 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Introduction

11.1.4 GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)

11.1.5 GlaxoSmithKline Recent Development

11.2 Eli Lilly

11.2.1 Eli Lilly Company Details

11.2.2 Eli Lilly Business Overview

11.2.3 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Introduction

11.2.4 Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)

11.2.5 Eli Lilly Recent Development

11.3 AstraZeneca

11.3.1 AstraZeneca Company Details

11.3.2 AstraZeneca Business Overview

11.3.3 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Introduction

11.3.4 AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)

11.3.5 AstraZeneca Recent Development

11.4 Bristol-Myers

11.4.1 Bristol-Myers Company Details

11.4.2 Bristol-Myers Business Overview

11.4.3 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Introduction

11.4.4 Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)

11.4.5 Bristol-Myers Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Details

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Immune-Mediated Inflammatory Diseases Treatment Introduction

11.5.4 Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)

11.5.5 Sanofi Recent Development

11.6 Roche

11.6.1 Roche Company Details

11.6.2 Roche Business Overview

11.6.3 Roche Immune-Mediated Inflammatory Diseases Treatment Introduction

11.6.4 Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)

11.6.5 Roche Recent Development

11.7 Enlivex Therapeutics

11.7.1 Enlivex Therapeutics Company Details

11.7.2 Enlivex Therapeutics Business Overview

11.7.3 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Introduction

11.7.4 Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)

11.7.5 Enlivex Therapeutics Recent Development

11.8 Immune Pharmaceuticals

11.8.1 Immune Pharmaceuticals Company Details

11.8.2 Immune Pharmaceuticals Business Overview

11.8.3 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Introduction

11.8.4 Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)

11.8.5 Immune Pharmaceuticals Recent Development

11.9 Tanabe Pharma

11.9.1 Tanabe Pharma Company Details

11.9.2 Tanabe Pharma Business Overview

11.9.3 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Introduction

11.9.4 Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)

11.9.5 Tanabe Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

Bristol myers

Sanofi

Roche

Enlivex Therapeutics

Immune Pharmaceuticals

Tanabe Pharma

GlaxoSmithKline

GlaxoSmithKline PLC

Eli Lilly

List of Tables

Table 1. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Targeted biologic therapies

Table 3. Key Players of Novel therapies

Table 4. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Region (2020-2025)

Table 8. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Region (2026-2031)

Table 10. Immune-Mediated Inflammatory Diseases Treatment Market Trends

Table 11. Immune-Mediated Inflammatory Diseases Treatment Market Drivers

Table 12. Immune-Mediated Inflammatory Diseases Treatment Market Challenges

Table 13. Immune-Mediated Inflammatory Diseases Treatment Market Restraints

Table 14. Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Players (2020-2025)

Table 16. Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2024)

Table 17. Ranking of Global Top Immune-Mediated Inflammatory Diseases Treatment Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Immune-Mediated Inflammatory Diseases Treatment, Headquarters and Area Served

Table 20. Global Key Players of Immune-Mediated Inflammatory Diseases Treatment, Product and Application

Table 21. Global Key Players of Immune-Mediated Inflammatory Diseases Treatment, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2020-2025)

Table 25. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2026-2031)

Table 27. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Application (2020-2025)

Table 29. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Application (2026-2031)

Table 31. North America Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. GlaxoSmithKline Company Details

Table 47. GlaxoSmithKline Business Overview

Table 48. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product

Table 49. GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)

Table 50. GlaxoSmithKline Recent Development

Table 51. Eli Lilly Company Details

Table 52. Eli Lilly Business Overview

Table 53. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product

Table 54. Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)

Table 55. Eli Lilly Recent Development

Table 56. AstraZeneca Company Details

Table 57. AstraZeneca Business Overview

Table 58. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product

Table 59. AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)

Table 60. AstraZeneca Recent Development

Table 61. Bristol-Myers Company Details

Table 62. Bristol-Myers Business Overview

Table 63. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product

Table 64. Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)

Table 65. Bristol-Myers Recent Development

Table 66. Sanofi Company Details

Table 67. Sanofi Business Overview

Table 68. Sanofi Immune-Mediated Inflammatory Diseases Treatment Product

Table 69. Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)

Table 70. Sanofi Recent Development

Table 71. Roche Company Details

Table 72. Roche Business Overview

Table 73. Roche Immune-Mediated Inflammatory Diseases Treatment Product

Table 74. Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)

Table 75. Roche Recent Development

Table 76. Enlivex Therapeutics Company Details

Table 77. Enlivex Therapeutics Business Overview

Table 78. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product

Table 79. Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)

Table 80. Enlivex Therapeutics Recent Development

Table 81. Immune Pharmaceuticals Company Details

Table 82. Immune Pharmaceuticals Business Overview

Table 83. Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Product

Table 84. Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)

Table 85. Immune Pharmaceuticals Recent Development

Table 86. Tanabe Pharma Company Details

Table 87. Tanabe Pharma Business Overview

Table 88. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product

Table 89. Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025) & (US$ Million)

Table 90. Tanabe Pharma Recent Development

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

Table 94. Authors List of This Report

List of Figures

Figure 1. Immune-Mediated Inflammatory Diseases Treatment Picture

Figure 2. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Type: 2024 VS 2031

Figure 4. Targeted biologic therapies Features

Figure 5. Novel therapies Features

Figure 6. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Pharmacy Store Case Studies

Figure 10. Online Pharmacy Stroe Case Studies

Figure 11. Immune-Mediated Inflammatory Diseases Treatment Report Years Considered

Figure 12. Global Immune-Mediated Inflammatory Diseases Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Immune-Mediated Inflammatory Diseases Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Region: 2024 VS 2031

Figure 15. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Players in 2024

Figure 16. Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2024

Figure 18. North America Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2020-2031)

Figure 20. United States Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2020-2031)

Figure 24. Germany Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Share by Region (2020-2031)

Figure 32. China Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2020-2031)

Figure 40. Mexico Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2020-2031)

Figure 44. Turkey Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. GlaxoSmithKline Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)

Figure 48. Eli Lilly Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)

Figure 49. AstraZeneca Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)

Figure 50. Bristol-Myers Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)

Figure 51. Sanofi Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)

Figure 52. Roche Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)

Figure 53. Enlivex Therapeutics Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)

Figure 54. Immune Pharmaceuticals Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)

Figure 55. Tanabe Pharma Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2020-2025)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions